HALO logo
halo search icon
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc.
COLL · NAS

Collegium Pharmaceutical, Inc.

US$34.42

Price Arrow0.20 (0.584%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownHALO AllHALO Capital EfficiencyHALO GARPHALO GrowthHALO Value+2
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Collegium Pharmaceutical, Inc. Overview

COLL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Strong

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About COLL

icon

Telephone

1.781.713.3699

icon

Address

Suite 300, 100 Technology Center Drive, Stoughton, MA 02072

Description

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

COLL Price Chart

Key Stats

Market Cap

US$1.11B

PE

26.70

EV/EBITDA

5.7

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 28.34 - 50.79

Trade Value (12mth)

US$4,292,247.00

1 week

1.3%

1 month

3.51%

YTD

-24.84%

1 year

18.74%

All time high

50.79

Key Fundamentals

EPS 3 yr Growth

-368.30%

EBITDA Margin

52.90%

Operating Cashflow

$329m

Free Cash Flow Return

28.00%

ROIC

5.30%

Interest Coverage

5.00

Quick Ratio

1.50

Other Data

Shares Outstanding (Fully Diluted)

40m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

COLL Announcements

Latest Announcements

DateAnnouncements
16 May 26
12 May 26
12 May 26
07 May 26
07 May 26

COLL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock1.432.141.98locklocklock
EPS (Fully Diluted)
$locklocklocklock1.291.861.73locklocklock
Growth
%locklocklocklock293.150.2-7.5locklocklock
PE
Xlocklocklocklock23.815.426.7locklocklock
EV/EBITDA
Xlocklocklocklock5.15.45.7locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Collegium Pharmaceutical, Inc. (COLL:NAS)?
Halo FAQ
The current share price of Collegium Pharmaceutical, Inc. (COLL:NAS) is USD$34.42.
What is the 52-week high share price for Collegium Pharmaceutical, Inc. (COLL:NAS)?
Halo FAQ
The 52-week high share price for Collegium Pharmaceutical, Inc. (COLL:NAS) is USD$50.79.
What is the 52-week low share price for Collegium Pharmaceutical, Inc. (COLL:NAS)?
Halo FAQ
The 52-week low share price for Collegium Pharmaceutical, Inc. (COLL:NAS) is USD$28.34.
What is the dividend yield for Collegium Pharmaceutical, Inc. (COLL:NAS)?
Halo FAQ
Collegium Pharmaceutical, Inc. (COLL:NAS) does not pay a dividend.
What was Collegium Pharmaceutical, Inc. (COLL:NAS) last dividend payment?
Halo FAQ
Collegium Pharmaceutical, Inc. (COLL:NAS) does not pay a dividend.
What is the franking level for Collegium Pharmaceutical, Inc. (COLL:NAS)?
Halo FAQ
Collegium Pharmaceutical, Inc. (COLL:NAS) has a franking level of 0.00%.
In which sector is Collegium Pharmaceutical, Inc. (COLL:NAS) classified?
Halo FAQ
Collegium Pharmaceutical, Inc. (COLL:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Collegium Pharmaceutical, Inc. (COLL:NAS)?
Halo FAQ
The current P/E ratio for Collegium Pharmaceutical, Inc. (COLL:NAS) is 26.70.

See beyond the curve.

One solution for research, investing and portfolio management.